Chesnara (CSN) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
6 Nov, 2026Deal rationale and strategic fit
Acquisition of 100% of MetLife UK Limited, adding scale and diversification to U.K. life and pensions operations.
Closed book comprises unit-linked investment policies with optional guarantees and variable annuities; it closed to new business in 2017.
Adds £1.7bn of assets under administration and ~18,000 policies; fully reinsured guarantee-bearing policies behave economically like unit-linked products and diversify the existing U.K. portfolio.
Financial terms and conditions
At completion under the target operating model, Own Funds and Contractual Service Margin are expected to increase by ~£45m; uplift equals ~5% of total Own Funds and nearly 10% of UT1.
Expected lifetime cash flows of ~£90m, with ~half expected to emerge in the first five years after completion.
Consideration is subject to customary completion adjustments and is not expected to be material; no material financing or capital contribution is expected, and available firepower is unchanged.
Group Solvency II ratio impact is expected to be broadly neutral; sensitivities are largely unaffected as portfolio risks diversify with the existing U.K. business.
Synergies and expected cost savings
Migration to the modern SS&C platform and associated rate card supports value creation; cash-flow projections use a prudent assumption for the long-term cost profile after migration.
Projected lifetime cash flows exclude future capital management actions, including potential mass-lapse actions, which remain possible sources of upside.
Latest events from Chesnara
- £53.0m commercial cash generation and 205% solvency support further M&A.CSN
H2 2023 - OCG up 79% to £96m, 6% dividend increase, and strong solvency at 185%.CSN
H1 2026 - Major acquisitions and strong capital generation underpin robust growth and future M&A focus.CSN
H2 2025 - Simplified metrics highlight sustainable capital and profit, enhancing transparency and comparability.CSN
Investor presentation - €110m Luxembourg deal adds €1.7bn assets, €250m cash, and boosts European expansion.CSN
M&A announcement - £37m cash generation, 207% solvency, and HSBC Life (UK) acquisition drive growth.CSN
H1 2025 - £260m acquisition and £140m rights issue drive scale, £800m cash flow, and dividend growth.CSN
M&A Announcement - £29.2m cash generation, 3% dividend growth, and 201% solvency highlight robust H1 2024.CSN
H1 2024 - Cash generation up 14%, solvency at 203%, and dividend up 3% with strong M&A momentum.CSN
H2 2024